News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Scientific articles 19 Aug 2026 A serological method’s ability to distinguish treatment regimens by assessing early antibody decline in Chagas patients: insights from E1224 data The Journal of Infectious Diseases
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
Scientific articles 9 Jul 2026 Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring PLOS Neglected Tropical Diseases
Scientific articles 7 Jul 2026 Integrating molecular similarity and alphafold-based structural alignment for target discovery in trypanosoma cruzi Pharmaceuticals
Scientific articles 24 Jun 2026 Inspiring, shaping and sustaining an African research & development agenda Nature Medicine
Scientific articles 22 Jun 2026 What Is in a Structure? Cell Permeability and Solubility of Series of Macrocycles and Linear Matched Pairs Journal of Medicinal Chemistry
Scientific articles 17 Jun 2026 Advancing diagnostics for Chagas disease: key product characteristics and harmonized evaluation strategies – an expert meeting report BMC Infectious Diseases
Scientific articles 8 Jun 2026 Screening strategies for Chagas Disease: evaluation of a diagnostic algorithm in the field in Santiago del Estero Revista de la Facultad de Ciencias Médicas de Córdoba
Scientific articles 5 Jun 2026 Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort PLOS Neglected Tropical Diseases
